Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BIO-TECHNE Corp TECH

Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are... see more

Recent & Breaking News (NDAQ:TECH)

Bio-Techne Announces Launch of Cultrex UltiMatrix BME to Support Organoid and Pluripotent Stem Cell Cultures

PR Newswire March 29, 2021

Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb

PR Newswire March 26, 2021

Bio-Techne's Exosome Diagnostics Laboratory Announces CE-IVD Certification For ExoDx Prostate Test

PR Newswire March 23, 2021

Kantaro Biosciences Named to Fast Company's Annual List of the World's Most Innovative Companies for 2021 and Ranked First in the Joint Ventures Category

PR Newswire March 10, 2021

Bio-Techne Announces ExoTRU Kidney Transplant Rejection Assay Data Publication

PR Newswire March 8, 2021

Bio-Techne to Acquire Asuragen

PR Newswire March 3, 2021

Bio-Techne To Present At The Barclays Global Healthcare Conference

PR Newswire March 2, 2021

Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With Humana

PR Newswire March 1, 2021

Bio-Techne Announces ISO 14001:2015 Certification for the EMEA region of Bio-Techne.

PR Newswire February 25, 2021

Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster(TM) for the development of Luminary's CAR-T cell therapies

PR Newswire February 23, 2021

Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference

PR Newswire February 16, 2021

Bio-Techne Announces Paper Publication In Annals Of Oncology

PR Newswire February 11, 2021

FDA Adds Kantaro's Semi-Quantitative COVID-19 Antibody Test to Revised Emergency Use Authorization for Convalescent Plasma

PR Newswire February 10, 2021

Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference

PR Newswire February 10, 2021

Kantaro and Atrys Health Partnership Expand Global Footprint of Quantitative COVID-19 Antibody Tests in Europe and South America

PR Newswire February 8, 2021

Bio-Techne Announces Expanded Simple Plex Immunoassay Cartridge Portfolio

PR Newswire February 3, 2021

Bio-Techne Declares Dividend

PR Newswire February 2, 2021

Bio-Techne Releases Second Quarter Fiscal 2021 Results

PR Newswire February 2, 2021

Bio-Techne Announces Strategic Investment In Eminence

PR Newswire January 28, 2021

Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results

PR Newswire January 14, 2021